BELLETTI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.610
EU - Europa 4.720
AS - Asia 1.458
SA - Sud America 28
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 14.849
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.583
GB - Regno Unito 1.683
IT - Italia 1.572
CN - Cina 492
SE - Svezia 391
DE - Germania 281
SG - Singapore 275
TR - Turchia 249
HK - Hong Kong 234
UA - Ucraina 212
FI - Finlandia 130
FR - Francia 127
BG - Bulgaria 82
IN - India 61
RU - Federazione Russa 43
KR - Corea 40
IE - Irlanda 31
NL - Olanda 29
IR - Iran 27
BE - Belgio 26
CA - Canada 22
RO - Romania 22
ID - Indonesia 20
CH - Svizzera 15
ES - Italia 13
LT - Lituania 12
IL - Israele 11
GR - Grecia 10
VN - Vietnam 10
EU - Europa 9
JP - Giappone 9
PL - Polonia 9
BR - Brasile 8
PT - Portogallo 8
IQ - Iraq 7
CO - Colombia 6
CZ - Repubblica Ceca 6
HU - Ungheria 6
CL - Cile 5
BZ - Belize 4
EG - Egitto 4
NZ - Nuova Zelanda 4
PE - Perù 4
PK - Pakistan 4
TW - Taiwan 4
AU - Australia 3
DZ - Algeria 3
MY - Malesia 3
SN - Senegal 3
YE - Yemen 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AT - Austria 2
BY - Bielorussia 2
DK - Danimarca 2
EC - Ecuador 2
LK - Sri Lanka 2
NG - Nigeria 2
NO - Norvegia 2
RS - Serbia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
GH - Ghana 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
Totale 14.849
Salva come PNG Salva come JPEG
Città #
Southend 1.500
Fairfield 1.060
Santa Clara 969
Woodbridge 696
Ashburn 645
Chandler 636
Jacksonville 452
Houston 439
Seattle 431
Wilmington 406
Dearborn 377
Ann Arbor 374
Cambridge 359
Nyköping 280
Hong Kong 231
Modena 223
Singapore 216
Beijing 164
Izmir 156
Princeton 90
Milan 85
Chicago 81
San Diego 81
Sofia 80
Eugene 79
Rome 55
Helsinki 54
New York 52
Redwood City 52
London 50
Fremont 48
Falls Church 47
Bologna 37
Bremen 34
Dublin 26
Napoli 26
Como 25
Brussels 23
Naples 23
Des Moines 22
San Giuliano Milanese 22
Tulare 21
Florence 20
Moscow 20
Munich 20
Reggio Emilia 18
Shanghai 18
Jakarta 17
Palermo 17
Norwalk 16
Hefei 15
Kocaeli 15
Genoa 14
Guangzhou 14
Los Angeles 14
Boardman 13
Catania 13
Parma 13
Frankfurt am Main 12
Nanjing 12
Perugia 12
Bari 11
Phoenix 11
Halifax 10
Turin 10
Bengaluru 9
Chennai 9
Kunming 9
Pescara 9
Dong-gu 8
Ferrara 8
Indiana 8
Mountain View 8
Saint Petersburg 8
Castelnuovo Di Porto 7
Dallas 7
Dongguan 7
Gandhinagar 7
Hounslow 7
Jinan 7
Paris 7
Rende 7
Salerno 7
Dong Ket 6
Padova 6
Saarbrücken 6
Toronto 6
Venezia 6
Washington 6
Wuhan 6
Zhengzhou 6
Brescia 5
Catanzaro 5
Changsha 5
Chengdu 5
Founex 5
Indianapolis 5
Kilburn 5
Lequile 5
Messina 5
Totale 11.294
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 396
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 391
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 311
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 297
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 280
Protein corona and nanoparticles: How can we investigate on? 264
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 261
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 260
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 253
Nanoparticle transport across the blood brain barrier 249
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 249
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 246
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 244
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 243
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 241
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 238
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 236
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 235
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 234
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 226
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 223
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 221
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 218
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 216
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 212
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 211
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 211
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 211
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 210
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 203
Functionalization of liposomes: microscopical methods for preformulative screening 203
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 201
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 201
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 201
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 200
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 200
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 199
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 193
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 191
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 187
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 186
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 184
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 183
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 182
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 181
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 172
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 172
Nanomedicine: the future for advancing medicine and neuroscience 168
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 168
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 167
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 165
TERAPIA NUTRIZIONALE PARENTERALE: APPROCCIO MULTIDISCIPLINARE, ORGANIZZATIVO E TECNOLOGICO 165
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 164
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 158
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE 156
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 153
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 149
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 149
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 149
Immunonanosystems to CNS pathologies: State of the art 148
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 147
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 146
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 146
Leptin-conjugated nanoparticles as drug delivery system to the brain 128
Nanotechnology and Central Nervous System Drug Delivery 127
Cholesterol nanoparticles partially rescue the alterations in synaptic phenotype of the R6/2 mouse model of Huntington's Disease 125
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 122
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 121
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 121
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 114
Ligand- based strategies to modified NPs surface for blood-brain barrier crossing 114
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 107
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 101
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 100
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 99
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 99
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 98
Nanotechnology in medicine: therapeutic strategies in neurological disorders 87
Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics (2016) 511 (1) (331-340) (S0378517316306512) (10.1016/j.ijpharm.2016.07.022)) 87
Nanomedicine in neurodegenerative disorders: Understanding the journey 79
Totale 15.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.304
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.090 0 0 0 0 0 414 508 358 406 117 207 80
2020/20212.563 357 92 172 222 214 173 194 302 112 489 141 95
2021/20221.675 100 153 169 79 55 102 101 111 189 144 272 200
2022/20231.816 198 222 153 181 199 237 55 183 201 29 74 84
2023/20241.324 72 66 90 98 293 139 144 171 37 39 58 117
2024/20251.751 169 53 62 284 755 428 0 0 0 0 0 0
Totale 15.053